(19)
(11) EP 1 527 083 A1

(12)

(43) Date of publication:
04.05.2005 Bulletin 2005/18

(21) Application number: 03740352.4

(22) Date of filing: 26.06.2003
(51) International Patent Classification (IPC)7C07H 19/167, A61K 31/70
(86) International application number:
PCT/EP2003/006749
(87) International publication number:
WO 2004/003002 (08.01.2004 Gazette 2004/02)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 27.06.2002 EP 02014324

(71) Applicant: Aventis Pharma Deutschland GmbH
65926 Frankfurt am Main (DE)

(72) Inventors:
  • BIGOT, Antony
    F-94400 Vitry-sur-Seine (FR)
  • STENGELIN, Siegfried
    65817 Eppstein (DE)
  • JÄHNE, Gerhard
    65929 Frankfurt am Main (DE)
  • HERLING, Andreas
    65520 Bad Camberg (DE)
  • MÜLLER, Günter
    65843 Sulzbach (DE)
  • HOCK, Franz, Jakob
    64807 Dieburg (DE)
  • MYERS, Michael, R.
    Fishers, IN 46038 (US)

(74) Representative: Isenbruck, Günter, Dr. 
Isenbruck, Bösl, Hörschler, Wichmann, HuhnPatentanwälteTheodor-Heuss-Anlage 12
68165 Mannheim
68165 Mannheim (DE)

   


(54) NOVEL ADENOSINE ANALOGUES AND THEIR USE AS PHARMACEUTICAL AGENTS